Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse - PubMed (original) (raw)
Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse
Y Nakashima et al. Arterioscler Thromb Vasc Biol. 1998 May.
Abstract
Focal recruitment of monocytes and lymphocytes is one of the earliest detectable cellular responses in the formation of lesions of atherosclerosis. This localized accumulation of leukocytes is a multistep process in which the endothelium remains intact and may regulate leukocyte recruitment by expressing specific adhesion molecules. To examine the relationship of adhesion molecule expression to initiation factors and the sites of lesion formation, we analyzed the expression of vascular cell adhesion molecule-1 (VCAM-1), intercellular adhesion molecule-1 (ICAM-1), and platelet-endothelial cell adhesion molecule-1 (PECAM-1) en face on the aortic endothelium of control mice and homozygous apolipoprotein E-deficient (ApoE -/-) mice that develop complex lesions of atherosclerosis similar to those in humans. In control mice, VCAM-1 staining was weak and limited to sites of altered blood flow. In contrast, in the ApoE -/- mice, VCAM-1 appeared to be localized over the surface of groups of endothelial cells in lesion-prone sites. Expression of VCAM-1 preceded lesion formation, and increased expression above control levels appeared to be correlated with the extent of exposure to plasma cholesterol. Although ICAM-1 was the most prominent adhesion molecule in lesion-prone sites, its expression appeared to be independent of plasma cholesterol levels and was upregulated in both ApoE -/- and control mice. At lesion-prone sites associated with altered blood flow, ICAM-1 was located over the surface of each endothelial cell and on microvilli, whereas VCAM-1 was confined to the cell periphery in non-lesion-prone sites. PECAM-1 was localized at the cell periphery throughout the aorta, and its expression did not appear to be regulated. Thus, the levels, localization, and characteristics of expression of VCAM-1, ICAM-1, and PECAM-1 appear to be differentially regulated. Upregulation of VCAM-1 and ICAM-1 is associated with sites of lesion formation.
Similar articles
- Patterns of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 expression in rabbit and mouse atherosclerotic lesions and at sites predisposed to lesion formation.
Iiyama K, Hajra L, Iiyama M, Li H, DiChiara M, Medoff BD, Cybulsky MI. Iiyama K, et al. Circ Res. 1999 Jul 23;85(2):199-207. doi: 10.1161/01.res.85.2.199. Circ Res. 1999. PMID: 10417402 - Adhesion of T and B lymphocytes to mouse atherosclerotic aortas: association with lesion topology and VCAM-1 expression.
Møller F, Andersen CB, Nielsen LB. Møller F, et al. Scand J Clin Lab Invest. 2005;65(7):559-70. doi: 10.1080/00365510500321564. Scand J Clin Lab Invest. 2005. PMID: 16271987 - Atherosclerosis and inflammation mononuclear cell recruitment and adhesion molecules with reference to the implication of ICAM-1/LFA-1 pathway in atherogenesis.
Watanabe T, Fan J. Watanabe T, et al. Int J Cardiol. 1998 Oct 1;66 Suppl 1:S45-53; discussion S55. doi: 10.1016/s0167-5273(98)00147-8. Int J Cardiol. 1998. PMID: 9951802 Review. - ICAM-1 and VCAM-1: Gatekeepers in various inflammatory and cardiovascular disorders.
Singh V, Kaur R, Kumari P, Pasricha C, Singh R. Singh V, et al. Clin Chim Acta. 2023 Aug 1;548:117487. doi: 10.1016/j.cca.2023.117487. Epub 2023 Jul 11. Clin Chim Acta. 2023. PMID: 37442359 Review.
Cited by
- Therapeutic Efficacy of Antioxidants in Ameliorating Obesity Phenotype and Associated Comorbidities.
Tun S, Spainhower CJ, Cottrill CL, Lakhani HV, Pillai SS, Dilip A, Chaudhry H, Shapiro JI, Sodhi K. Tun S, et al. Front Pharmacol. 2020 Aug 13;11:1234. doi: 10.3389/fphar.2020.01234. eCollection 2020. Front Pharmacol. 2020. PMID: 32903449 Free PMC article. Review. - BubR1 Insufficiency Results in Decreased Macrophage Proliferation and Attenuated Atherogenesis in Apolipoprotein E-Deficient Mice.
Tanaka S, Matsumoto T, Matsubara Y, Harada Y, Kyuragi R, Koga JI, Egashira K, Nakashima Y, Yonemitsu Y, Maehara Y. Tanaka S, et al. J Am Heart Assoc. 2016 Sep 24;5(9):e004081. doi: 10.1161/JAHA.116.004081. J Am Heart Assoc. 2016. PMID: 27664806 Free PMC article. - Bioactive TNIIIA2 Sequence in Tenascin-C Is Responsible for Macrophage Foam Cell Transformation; Potential of FNIII14 Peptide Derived from Fibronectin in Suppression of Atherosclerotic Plaque Formation.
Iyoda T, Ohishi A, Wang Y, Yokoyama MS, Kazama M, Okita N, Inouye S, Nakagawa Y, Shimano H, Fukai F. Iyoda T, et al. Int J Mol Sci. 2024 Feb 2;25(3):1825. doi: 10.3390/ijms25031825. Int J Mol Sci. 2024. PMID: 38339104 Free PMC article. - Interleukin-17 and acute coronary syndrome.
Su SA, Ma H, Shen L, Xiang MX, Wang JA. Su SA, et al. J Zhejiang Univ Sci B. 2013 Aug;14(8):664-9. doi: 10.1631/jzus.BQICC701. J Zhejiang Univ Sci B. 2013. PMID: 23897784 Free PMC article. Review. - The enhanced expression of IL-17-secreting T cells during the early progression of atherosclerosis in ApoE-deficient mice fed on a western-type diet.
Jeon US, Choi JP, Kim YS, Ryu SH, Kim YK. Jeon US, et al. Exp Mol Med. 2015 May 15;47(5):e163. doi: 10.1038/emm.2015.19. Exp Mol Med. 2015. PMID: 25976521 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous